In Gastroenterology, News, Press Release


WCCT Global Expands Clinical Pharmacology Services in Gastroenterology

COSTA MESA, Calif., May 29, 2015/IReach-PRNewswire/–WCCT Global, a full service CRO, is expanding upon its clinical pharmacology services through the acquisition of Inland Empire-based firm United Gastroenterologists, and the appointment of Dr. John Hong to the WCCT team to lead Phase I to Phase IV clinical research activities in Gastroenterology. Since its inception in 1998, the contract research organization has made every effort to offer Phase I clinical pharmacology expertise in a many therapeutic areas of clinical research; now, Phase II to IV GI clinical research will be added to its Phase I GI capabilities.

Many innovative GI clinical pharmacology procedures can be performed at the newly acquired outpatient/surgical centers,. The centers are capable of supporting outpatient clinical trials and clinical pharmacology services for the following conditions: Chrohn’s disease, ulcerative colitis, irritable bowel syndrome, constipation and diarrhea, Hepatitis B/C, NASH, and weight loss/obesity. Additionally, clinical research capabilities at many of the sites will be expanded to enable support of outpatient support in other therapeutic areas. This acquisition now gives WCCT Global access to a large patient database for a number of conditions within the field of Gastroenterology.

WCCT Global’s CEO, Kenneth Kim, had this to say about the contract research organizations new service offerings: “I am excited to have Dr. Hong join our team as the new Medical Director of Gastroenterology. As a company, we’ve prided ourselves on being able to offer a wide array of clinical pharmacology services in many therapeutic areas. I feel that Dr. Hong is well equipped to lead our clinical research team as we enhance our Phase I GI expertise with the addition of Phase II to IV full service GI clinical trial support. He is an accomplished Gastroenterologist and has built an impressive GI clinical practice; WCCT would not have made this acquisition if we didn’t feel that United Gastroenterologists held itself to the same high standards that we do when it comes to conducting clinical research.”

The full-service CRO is now fully prepared to offer clinical pharmacology services in all areas of Gastroenterology, and looks forward to conducting further research in this field.

Start typing and press Enter to search